1- Melbye M, Rabkin C, Frisco M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol. 1994,139:772-780.

2- Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, Villalon-Gomez JM, Williams M, Cress RD. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008;113(S10):2892"“2900.

3- Holmes F, Borek D, Owen-Kummer M, Hassanein R, Fishback J, Behbehani A, Baker A, Holmes G. Anal cancer in women. Gastroenterology. 1988, 95:107-111.

4- Johnson LG, Madeleine MM, Newcomer LM, et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004, 101: 281-288.

5- http://www.cancer.org/cancer/analcancer/detailedguide/anal-cancer-what-is-key-statistics.Last Medical Review: 01/02/2013

6- Palesfky JM, Holly EA, Gonzalez J, Berline J, Ahn DK, Greenspan JS. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res. 1991, 51:1014-1019.

7- Koulos J, Symmans F, Chumas J, Nuovo G. Humanpapillomavirus detection in adenocarcinoma of the anus. Mod Pathol. 1991 Jan;4(1):58-61

8- DalingJR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Carter JJ, Porter PL, Galloway DA, McDougal JK. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004, 101:270-280.

9- De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. International Journal of Cancer 2009;124(7):1626"“1636.

10- Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000, 342: 792-800.

11- Northfelt DW. Cervical and anal neoplasia and HPV infection in persons with HIV infection. Oncology 1994, 8:32"“37.

12- Melbye M, Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991, 338:657"“659.

13- Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527.

14- zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989;49:4677-4681.

15- Chen T, Pecaro G, Defendi V. Genetic analysis of in vitro progression of human papillomavirus transfected human cervical cells. Cancer Res 1993; 53:1167"“71.

16- Fenger C. Anal Neoplasia and its precursors: Facts and Controversies. Sem Dig Pathol 1991;8:190-201.

17- Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, et al. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 1998; 58:3839"“44.

18- Scholefield JH, Hickson WGE, Smith JHF, Rogers K, Sharp F. Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet 1992;340:1271-1273.

19- Daling JR et al. Sexual practices, sexually transmitted diseases and the incidence of anal cancer. N Engl J Med 1987;317:973-977.

20- 19- Sonnex C.ac. et al. Anal Human Papillomavirus infection in heterosexuals with genital warts: prevalence and relation with sexual behaviour. BMJ 1991;303:1243.

21- Frisch M, Glimelius D, van der Brule AJC, Wahlfahrt Jet al. Sexually transmited infection as a cause of anal cancer. New Engl J. Med 1997,337:1350-1358.

22- Rock B, Shah KV, Farmer ER. A morphologic, pathologic, and virologic study of anogenital warts in men. Arch Dermatol 1992;127:495-500.

23- Ramanujam PS, Venkatesh KS, Co Barnett T, Fietz MJ. Study of Human Papillomavirus infection in patients with anal squamous carcinoma. Dis Colon Rectum 1996;39:37-39.

24- Gius D, Funk MC, Chuang EY, Feng S, Huettner PC, Nguyen L, Bradbury CM, Mishra M, Gao S, Buttin BM, Cohn DE, Powell MA, Horowitz NS, Whitcomb BP, Rader JS. Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates. Cancer Research 2007, 67, 7113-7123

25- Molina J, Guzmán Bistoni C, Méndez V, Blasco-Olaetxea E, Garcí­a Tamayo J. 2005. Alteraciones cromosómicas en el cáncer del cuello uterino. Vitae-Academia Biomédica Digital Octubre-diciembre 2005. Disponible en: http://vitae.ucv.ve/?module=articulo&rv=11&n=514

26- Molina J, Arenas de S, A, Blasco Olaetxea E, Garcí­a Tamayo J. Hibridación Genómica Comparada: Una revisión de los estudios sobre las alteraciones cromosómicas en la neoplasia intraepitelial y el carcinoma cervical durante la infección con el VPH. Academia Biomédica Digital-Vitae, abril "“junio 2010. Disponible en: http://vitae.ucv.ve/?module=articulo&rv=94&n=4165

27- McCance DJ, Kopan R, Fuchs E, Laimins LA: Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA 1988, 85:7169-7173.

28- Narisawa-Saito N, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Science 2007, 98: 1505-1511

29- Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991, 253:49-53.

30- Heim S, Mitelman F: Cancer Cytogenetics, New York, Wiley-Liss, 1995.

31- Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 1999, 25:195"“204.

32- Van Dekken H, Rosenberg C, Krijtenburg P, Alers J. Interphase cytogenetics and comparative genomic hybridization of human epithelial cancers and precursor lesions. Histochem Cell Biol 1997, 108:419"“ 430

33- Kurtycz D, Nunez M, Arts T, Bauman C, Harris C, Inhorn S, Meisner L. Use of fluorescent in situ hybridization to detect aneuploidy in cervical dysplasia. Diagn Cytopathol 1996, 15:46"“ 51.

34- Zhang A, Maner S, Betz R, Angstrom T, Stendahl U, Bergman F, Zetterberg A, Wallin KL. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer 2002, 101:427"“ 433.

35- Mian C, Bancher D, Kohlberger P, Kainz C, Haitel A, Czerwenka K, Stani J, Breitenecker G, Wiener H. Fluorescence in situ hybridizationin cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection. Gynecol Oncol 1999, 75:41"“ 46.

36- Heselmeyer K, Macville M, Schrock E, Blegen H, Hellstrom AC, Shah K, Auer G, Ried T. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q.Genes Chromosomes Cancer 1997, 19:233"“240.

37- Dellas A, Torhorst J, Jiang F, Proffitt J, Schultheiss E, Holzgreve W, Sauter G, Mihatsch MJ, Moch H. Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization. Cancer Res1999, 59:3475"“3479.

38- Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, Lundsteen C, Bryndorf T, Kryger-Baggesen N, Christensen L, Engelholm SA, Philip J. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes. Cancer 1999, 24:144"“150.

39- Allen DG, White DJ, Hutchins AM, Scurry JP, Tabrizi SN, Garland SM, Armes JE. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 2000, 83:1659"“1663.

40- Yang YC, Shyong WY, Chang MS, Chen YJ, Lin CH, Huang ZD, Wang, Hsu MT, Chen ML. Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genet Cytogenet 2001, 131:48"“53.

41- Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, Ogata H, Suminami Y, Sakamoto M, Sasaki K, Kato H. Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 2002, 33:98"“ 102.

42- Hidalgo A, Schewe C, Petersen S, Salcedo M, Gariglio P, Schluns K, Dietel M, Petersen I. Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines. Eur J Cancer 2000, 36:542"“548.

43- Matthews CP, Shera KA, McDougall JK. Genomic changes and HPV type in cervical carcinoma. Proc Soc Exp Biol Med 2000, 223:316"“ 321.

44- Hopman AH, Smedts F, Dignef W, et al. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol. 2004, 202:23-33.

45- Thorland EC, Myers SL, Gostout BS, et al. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene. 2003, 22:1225-1237.

46- Choo KB, Lee HH, Liew LN, et al. Analysis of the unoccupied site of an integrated human papillomavirus 16 sequence in a cervical carcinoma. Virology. 1990, 178:621-625.

47- Kahn T, Turazza E, Ojeda R, et al. Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. Cancer Res. 1994, 54:1305-1312.

48- Heselmeyer K, du Manoir S, Blegen H, et al. A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas. Br J Cancer. 1997;76:1271-1278.

49- Guzmán-Bistoni C, Pinillos B, Blanco-Arias MC, Arenas de Sotolongo A, Molina J, Garcí­a-Tamayo J, Blasco-Olaetxea E. Expression of blood group-related antigens in neoplastic uterine cervix. Clin Transl Oncol. 2008,10:227-230

50- Garcí­a Tamayo J, Molina J, Blasco-Olaetxea E. Importancia de los estudios de inmunohistoquí­mica en el diagnóstico y la evaluación pronóstica de la neoplasia intraepitelial y el cáncer cervical. Investigación Clí­nica 2009, 50: 241-250